Patent details

EP3333161 Title: 2-(2,4,5-SUBSTITUTED-ANILINO)PYRIMIDINE DERIVATIVES AS EGFR MODULATORS USEFUL FOR TREATING CANCER

Basic Information

Publication number:
EP3333161
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP171943079
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
2-(2,4,5-SUBSTITUTED-ANILINO)PYRIMIDINE DERIVATIVES AS EGFR MODULATORS USEFUL FOR TREATING CANCER
French Title of Invention:
DÉRIVÉS DE 2-(2,4,5-SUBSTITUÉ-ANILINO)PYRIMIDINE UTILISÉS COMME MODULATEURS DU RÉCEPTEUR EGFR UTILES POUR LE TRAITEMENT DU CANCER
German Title of Invention:
2-(2,4,5-SUBSTITUIERTES-ANILIN)PYRIMIDIN-DERIVATE ALS EGFR-MODULATOREN ZUR BEHANDLUNG VON KREBS
SPC Number:

Dates

Filing date:
25/07/2012
Grant date:
19/02/2020
EP Publication Date:
13/06/2018
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
19/02/2020
EP B1 Publication Date:
19/02/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
25/07/2032
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
12/02/2020
 
 

Name:
Astrazeneca AB
Address:
Forskargatan 18, 151 85 Södertälje, Sweden (SE)

Agent

Name:
ARONOVA S.A.
From:
17/04/2020
Address:
PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Inventor

1

Name:
REDFEARN, Heather, Marie
Address:
United Kingdom (GB)

2

Name:
CHUAQUI, Claudio, Edmundo
Address:
United States (US)

3

Name:
CHINTAKUNTLA, Chandrasekhara, Reddy
Address:
United Kingdom (GB)

4

Name:
MURUGAN, Andiappan
Address:
United Kingdom (GB)

5

Name:
FINLAY, Maurice, Raymond, Verschoyle
Address:
United Kingdom (GB)

6

Name:
KADAMBAR, Vasantha, Krishna
Address:
United Kingdom (GB)

7

Name:
BUTTERWORTH, Sam
Address:
United Kingdom (GB)

8

Name:
WARD, Richard, Andrew
Address:
United Kingdom (GB)

Priority

1

Priority Number:
201161512061 P
Priority Date:
27/07/2011
Priority Country:
United States (US)

2

Priority Number:
201261591363 P
Priority Date:
27/01/2012
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/437; A61K 31/506; A61P 35/00; C07D 401/02; C07D 471/04;

Publication

European Patent Bulletin

1

Issue number:
202008
Publication date:
19/02/2020
Description:
Grant (B1)

2

Issue number:
202013
Publication date:
25/03/2020
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
31/07/2025
Annual Fee Number:
14
Annual Fee Amount:
198 Euro
Expected Payer:
Last Annual Fee Payment Date:
11/07/2024
Last Annual Fee Paid Number:
13
Last Annual Fee Paid Amount:
180 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
17/04/2020 Power Of Attorney 1
17/04/2020 Outgoing Correspondence 1